标题: |
青光眼患者临床用药指南 |
title: |
Clinical Medication Guidelines for Glaucoma |
版本: |
原创版 |
version: |
Original |
分类: |
标准指南 |
classification: |
Standard guideline |
领域: |
治疗 |
field: |
Treatment |
国家和地区: |
中国 |
Country and
region:
|
China |
指南使用者: |
眼科医师、药师与护师 |
Guide users:
|
Ophthalmologist, pharmacist and nurse |
证据分级方法: |
GRADE system |
Evidence grading
method:
|
|
制定单位: |
中国药学会医院药学专业委员会、中国药学会循证药学专业委员会、北京大学第三医院药剂科、北京大学医学部药物评价中心 |
Formulating unit: |
the Chinese Pharmaceutical Association, Hospital Pharmacy Professional Committee; the Chinese Pharmaceutical Association, Evidence-based Pharmacy Professional Committee; Peking University Third Hospital; Institute for drug evaluation, Peking University Health Science Center |
注册时间: |
2021-01-15 |
Registration time: |
注册编号: |
IPGRP-2021CN009 |
Registration number: |
指南制订的目的: |
旨在基于循证药学的方法,整合眼科药学资源与力量,总结当前可获得的青光眼患者临床用药的最佳循证证据,结合医生经验与患者意愿,为青光眼患者临床用药提供适宜的推荐意见。 |
Purpose of the guideline:
|
Based on the method of evidence-based pharmacy, this guideline aims to integrate the resources and strength of ophthalmology pharmacy, summarize the best evidence available for clinical medication of glaucoma patients, and provide appropriate recommendations for clinical medication of glaucoma patients combined with physicians' experience and patients' preference. |